National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials (PDQ®)
Patient VersionHealth Professional Version
Last Modified: 7/10/2008     First Published: 12/21/2002  
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Clinical Trial Questions?

Get Help:

1-800-4-CANCER or

LiveHelp online chat

Quick Links
Help Using the NCI Clinical Trials Search Form

Educational Materials About Clinical Trials

About NCI's Cancer Clinical Trials Registry

Dictionary of Cancer Terms

NCI Drug Dictionary
Related Links
Educational Materials About Clinical Trials

Clinical Trials

Questions to Ask Your Doctor

Drug Information from MedlinePlus
Vaginal Changes and Sexual Function in Patients With Cervical Cancer

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Related Information
Registry Information

Alternate Title

Study of Vaginal Length, Elasticity, Lubrication, and Sexual Function in Patients With Stage IB2 Cervical Cancer

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
No phase specifiedNatural history/EpidemiologyCompletedUnder 70NCIGOG-8003
NCT00053261

Trial Description

Purpose:

Vaginal changes that may effect sexual function occur in patients undergoing treatment for cervical cancer.

Clinical trial to determine the type of vaginal changes such as vaginal dryness that occur in patients receiving treatment for cervical cancer and the effect these changes have on sexual function.

Eligibility:

Eligibility criteria include the following:

  • Younger than 70 years old
  • Must be enrolled in clinical trial GOG-0201 or receiving similar treatment
  • For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will undergo a pelvic exam to determine the size of the vagina. Patients will then complete questionnaires over a 2-year period about vaginal dryness and sexual activity, response, and satisfaction. Pelvic exams will be repeated periodically for 2 years. Patients will be evaluated every 3 months for 2 years.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Gynecologic Oncology Group

Deborah Watkins Bruner, RN, PhD, Protocol chair
Ph: 215-728-2707; 888-369-2427

Related Information

PDQ® clinical trial GOG-0201

Registry Information
Official Title Vaginal Length, Elasticity, Lubrication And Sexual Function In Women With Stage IB2 Cervix Carcinoma
Trial Start Date 2003-07-21
Trial Completion Date 2007-01-14
Registered in ClinicalTrials.gov NCT00053261
Date Submitted to PDQ 2002-11-20
Information Last Verified 2005-06-07
NCI Grant/Contract Number CA27469

Back to TopBack to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov